CADUET

This brand name is authorized in Austria, Australia, Canada, Spain, France, Hong Kong, Japan, Lithuania, Malta, Mexico, Nigeria, Romania, Singapore, Tunisia, Turkey, United States, South Africa

Active ingredients

The drug CADUET contains a combination of these active pharmaceutical ingredients (APIs):

1 Amlodipine
UNII 864V2Q084H - AMLODIPINE BESYLATE

Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.

Read about Amlodipine
2 Atorvastatin
UNII 48A5M73Z4Q - ATORVASTATIN CALCIUM TRIHYDRATE

Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase. Atorvastatin lowers plasma cholesterol and lipoprotein serum concentrations by inhibiting HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.

Read about Atorvastatin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
CADUET Film-coated tablet Marketing Authorisation Holder MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C10BX03 Atorvastatin and amlodipine C Cardiovascular system → C10 Lipid modifying agents → C10B Lipid modifying agents, combinations → C10BX Lipid modifying agents in combination with other drugs
Discover more medicines within C10BX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 9051J, 9052K, 9053L, 9054M, 9055N, 9056P
Country: CA Health Products and Food Branch Identifier(s): 02273233, 02273241, 02273268, 02273276, 02273284, 02273292, 02273306, 02273314
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 67325, 67326
Country: FR Base de données publique des médicaments Identifier(s): 60386460, 60772273, 63123849, 65364681, 66709963
Country: HK Department of Health Drug Office Identifier(s): 53714, 53715, 53716, 53717, 53718, 53719, 53720, 53721
Country: JP 医薬品医療機器総合機構 Identifier(s): 2190101F1020, 2190102F1025, 2190103F1020, 2190104F1024
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1005137, 1005138, 1021103, 1021104, 1021105, 1021106, 1021107, 1021108, 1021109, 1021110, 1021111, 1021112, 1021113, 1021114, 1021115, 1021116, 1021117, 1021118, 1021119, 1021120, 1021121, 1021122, 1021123, 1021124, 1021125, 1021126
Country: MT Medicines Authority Identifier(s): MA1396/00201, MA1396/00202
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 204M2004
Country: NG Registered Drug Product Database Identifier(s): 04-8468
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W67262001, W67263001
Country: SG Health Sciences Authority Identifier(s): 13055P, 13056P, 13057P, 13059P, 13060P, 13061P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 26323011, 26323012
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699532095633, 8699532095640, 8699532095671, 8699532095688
Country: US FDA, National Drug Code Identifier(s): 0069-2150, 0069-2160, 0069-2170, 0069-2180, 0069-2190, 0069-2250, 0069-2260, 0069-2270
Country: ZA Health Products Regulatory Authority Identifier(s): A39/7.0/0326, A39/7.0/0327, A39/7.0/0328, A39/7.0/0329, A39/7.0/0330, A39/7.0/0331, A39/7.0/0332, A39/7.0/0333

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.